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Summary: In the present study, phagocytosis and the oxidative metabolism of neutrophil granulocytes from five
clinically healthy persons with different degrees of myeloperoxidase deficiency were investigated and compared to
those of normal persons. The identification of individuals with myeloperoxidase deficiency was performed with the
Bayer/Technicon H3 blood cell counter, which differentiates the leukocytes by measuring the peroxidase activity.
Neutrophils of three out of five investigated myeloperoxidase deficient persons showed extremly low peroxidase
indices (—53 and lower), but only the neutrophils of one person totally lacked myeloperoxidase. This was demon-
strated by comparing myeloperoxidase mass concentration measured with an enzyme immunoassay, lack of HOC1
production, and was further confirmed by measuring luminol- and lucigenin-enhanced chemiluminescence. Charac-
teristically, myeloperoxidase deficient granulocytes showed a strikingly decreased luminol-enhanced chemilumines-
cence while the lucigenin-enhanced chemiluminescence was significantly increased compared to normal granulo-
cytes. Although there is a DNA sequence homology of about 70%, the activity of peroxidase in eosinophils was
not affected in any myeloperoxidase deficient person investigated. Moreover, a person with a very rare defect of
eosinophil peroxidase had completely normal myeloperoxidase activity. The lack of myeloperoxidase activity is
compensated for by an increased phagocytic activity, an increased production of Superoxide anion (lucigenin-
chemiluminescence) and probably by an alternative metabolism of H2O2; since persons lacking myeloperoxidase
activity do not normally suffer from severe infections, H2O2 is obviously metabolized to other reactive oxygen
substrates than HOC1, e. g. to OH-radicals.
Introduction
Neutrophil granulocytes are the first line of defence
against invading microorganisms such as bacteria and
fungi (1). Apart from other defence mechanisms, the gen-
eration of reactive oxygen compounds plays an important
role in this process. After the activation of an NADPH-
oxidase2) complex, Superoxide anion is generated, which
is disproportionated to oxygen and H2O2, from which the
highly potent HOC1 is generated in the myeloperoxidase
reaction. Neutrophil granulocytes, and to a lesser degree
monocytes, contain myeloperoxidase-rich azurophil
granules. Eosinophil granulocytes contain another perox-
idase, the eosinophil peroxidase, which shares about 70%
DNA sequence homology with myeloperoxidase (2). The
different pattern of peroxidase content in the white blood
cell fraction is the basis for leukocyte differentiation by
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2) Enzymes:
Catalase,EC 1.11.1.6
Eosinophil peroxidase, EC 1.11.1.-
Myeloperoxidase, EC 1.11.1.7
NADPH-oxidase, EC 1.6.99.6
Superoxide dismutase, EC 1.15.1.1
an automatic blood cell counter, the Bayer/Technicon H3.
The introduction of such systems in routine blood cell
analysis contributed mainly to the detection of partial or
complete myeloperoxidase deficiency, which is a rather
frequent event (prevalence of 1 :2000-1 :4000) (3).
Considering the important role of HOC1 for effective kill-
ing of microorganisms, it is surprising that most myelo-
peroxidase deficient persons do not suffer from life threat-
ening infections more frequently than persons with nor-
mal myeloperoxidase activity. This fact stands in severe
contrast to persons whose granulocytes are deficient in
NADPH-oxidase (chronic granulomatous disease) and
consequently do not produce any reactive oxygen com-
pounds. Therefore, these cells are not able to kill patho-
gens that are catalase-positive and/or do not generate en-
dogenous H2O2 (4). Thus, in myeloperoxidase deficient
cells there is obviously an interplay of other mechanism,
which compensate for the inability to generate HOC1
from H2O2.
In the present study, we characterize the phagocytic ac-
tivity and the oxygen metabolism of granulocytes in 5
clinically healthy persons with different degrees of mye-
loperoxidase deficiency compared to persons with nor-
mal myeloperoxidase content.
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Materials and Methods
Probands
Five clinically healthy myeloperoxidase deficient blood donors (4
females, I male) (mean peroxidase index ranged between -30 and
-58) were found by routine analysis on the Bayer/Tcchnicon H3.
They are unrelated probands and their age ranged from 25-40
years. Proband 6 (a six year old girl, suffering from dystrophia of
unclear origin) with a rare eosinophil peroxidase deficiency was
found by routine blood measurement on the H3. Normal blood
controls of 5 healthy persons, aged between 25-45 years, were
selected, based on their myeloperoxidase activity. Founded on mea-
surements of several thousand healthy donors, the mean peroxidase
index was arbitrarily set as "zero" by the manufacturer (5, 6) and
the values of the mean peroxidase index between -1-10 and -10
were considered as 'normal'. The mean peroxidase index of an
individual sample was calculated by the H3 according to the equa-
tion:
(MPX)a - (MPX)n
(MPX)n X 100 = mean peroxidase index
(MPX)a: mean peroxidase activity of the current sample
(MPX)n: mean peroxidase activity of a collection of normal do-
nors.
Cell coun t ing and measurement of myeloperoxidase
ac t iv i ty
Blood cell analysis was carried out by flow cytometry using the
Bayer/Technicon H3. Differentiation of leukocytes was performed
by peroxidase staining and by simultaneous measurement of light-
scattering ("perox-chanel"). For peroxidase staining, red cells were
lysed in the H3-integrated "perox-chamber", and leukocytes were
fixed with formalin and stained for peroxidase using H2O2 and 4-
chloro-1-naphthol as chromogen (7, 8). The cell distribution pattern
was plotted by a socalled leukogram with peroxidase activity on
the x-axis and light-scattering on the y-axis (see fig. 1). In parallel,
low and wide angle scattering of cell nuclei is also registrated ("ba-
sophilic chanel", not shown in fig. 1).
Chemica l s and media
Histopaque® 1119 and 1077; phorbol 12-myristate 13-acetate; cata-
lase (40000-60000 U/mg); Superoxide dismutase (30000 U/mg);
bovine serum albumin; ferricytochrome c; 5,5'-dithio-bis(2-nitro-
benzoic acid); Na-dithionite; 5-amino-2.3-dihydro-l,4-phthalaz-
inedione (luminol) and bis-N-methylacridinium nitrate (lucigenin)
were purchased from Sigma (M nchen, Germany). Hanks' bal-
anced salt solution (with Ca^/Mg2"1", but without phenol red) and
phosphate buffered saline were purchased from Biochrom (Berlin,
Germany); Zymosan: from ICN (Eschwege, Germany) and H2O2
(300 g/kg) from Merck (Darmstadt, Germany).
Opsonized zymosan was prepared by incubation of 250 mg zymo-
san with 25 ml of human pool serum for 30 minutes at 37 °C. After
washing, opsonized zymosan was suspended in 3.5 ml phosphate
buffered saline and frozen until use (9).
Isolation of polymorphonuclear leukocytes
Polymorphonuclear leukocytes were isolated from heparinized
whole blood loaded on a two step density gradient with Histo-
paque® 1119 and 1077 by centrifugation at 500 g, at 2l°C for
25 minutes. Polymorphonuclear leukocytes were collected, washed
twice in Hanks' balanced salt solution with Ca2+/Mg2"1" and con-
taminating erythrocytes were lysed using an ice-cold ammonium
chloride buffer (8.29 g/1) for 15 minutes. The resulting polymor-
phonuclear leukocytes were counted and adjusted to the desired
concentration by adding Hanks' balanced salt solution with Ca247
Mg2+.
For separating the eosinophil granulocytes from neutrophils, the
magnetic cell sorter technique (Miltenyi Biotec, Bergisch Glad-
bach, Germany) was used (10). Cells were incubated with an anti-
CD16-antibody conjugated with superparamagnetic microbeads
(Miltenyi Biotec, Bergisch Gladbach, Germany). Incubating the
granulocytes with this antibody leads to a binding of marked neu-
trophils by passing the cell-suspension through a magnetic column.
The unmarked eosinophils are found in the eluate (purity 82%),
the neutrophils are retained and washed out with phosphate buf-
fered saline after separating the column from the magnetic field
(purity 98%). The resulting cells were used for determination of
cross-reactivity of myeloperoxidase and eosinophil peroxidase with
the enzyme immunoassay (see below).
Phagocytosis assay
A commercially available test kit from Orpegen (Heidelberg, Ger-
many) was used according to the manufacturer's instructions. The
test was intended to investigate the phagocytic activity of polymor-
phonuclear leukocytes and macrophages by flow cytometry adding
fluorescein isothiocyanate-loaded E. coli. Fluorescence activated
cell scan analysis permits the determination of the percentage of
granulocytes which can phagocytose fluorescein isothiocyanate-la-
beled E. coli as well as phagocytic activity of every individual cell.
Flow cytometry was carried out on a fluorescence activated cell
scan from Becton-Dickinson (Heidelberg, Germany). The data
were analyzed using the Lysis II program from Becton-Dickinson.
Myeloperoxidase enzyme immunoassay
The myeloperoxidase enzyme immunoassay kit (Biermann, Bad
Nauheim, Germany) is an enzyme linked immunosorbent assay for
measuring myeloperoxidase mass concentrations in several biolog-
ical samples. Isolated granulocytes (2 Χ 106 cells, or in some ex-
periments, neutrophils and eosinophils, previously separated by
magnetic cell sorting) were homogenized in 1 ml Tween 80/phos-
phate buffered saline (1 ml/1) by 3 cycles of freezing (-70 °C) and
thawing (37 °C) and sonicated for 30 seconds. The final suspension
was centrifuged at 12 000 g for 15 minutes and the supernatant was
collected and analyzed. The immunological cross-reactivity toward
the eosinophil peroxidase has been evaluated as lower than 2%
(product information of Biermann, Bad Nauheim).
O2 consumption and H202 measurement
The initial rate of oxygen consumption of polymorphonuclear leu-
kocytes (3.75 X 106/1 ml Hanks' balanced salt solution) Was mea-
sured under basal and stimulated conditions (addition of 100 μΐ
opsonized zymosan (10:1 diluted)) using a Clark electrode (Bach-
ofer, Reutlingen, Germany) at 37 °C for 5-10 minutes (9). The
steadystate concentration of H202 was measured 5 minutes after
the addition of opsonized zymosan to the cell suspension. For this
purpose, 10 μΐ of catalase solution [60 units] were added to the
incubation chamber and the increase in oxygen was monitored ac-
cording to the equation
H202 — H20 + 1/2 02
An H2O2 calibration curve was established by adding increasing
amounts of H202 to 1 ml incubation buffer [containing 60 units
catalase] which was previously partially deoxygenated by a step-
wise addition of small amounts of sodium dithionite.
Superoxide anion assay
Superoxide anion production was determined as Superoxide dismu-
tase-inhibitable reduction of ferricytpchrome c by a microassay ac-
cording to Mayo & Curnittte (11). Into each well of a 96-well plate
50 μΐ of the polymorphonuclear leukocyte suspension (7.5
X 109/1), 50 μΐ ferricytochrome c (2.7 g/1) and bovine serum albu-
mm/Hanks' balanced salt solution (80 g/1) were placed. Into refer-
ence wells-50 μΐ of Superoxide dismutase (1.25 g/1) were added.
Granulocytes were stimulated with phorbol myristate acetate (20
μg/l) and incubated at 37 °C for 30 minutes. Thereafter, wells were
measured at 550 nm with a microplate reader (Dynatech, Denken-
dorf, Germany). After complete reduction of ferricytochrome c by
addition of 10 μΐ Na-dithionite (half-saturated solution), the whole
amount of reduced ferricytochrome c was measured again at 550
nm to obtain the relation of the ferricytochrome reduced by ΟΪ"
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and the total amount of fcrricytochrome. C>2 produced by polymor-
phonuclear leukocytes was calculated as the difference between
Superoxide dismutase-containing samples and samples without su-
peroxidc dismutase (relation of reduced to total reduced ferricy-
tochrome c).
fercd saline with Ca2+/Mg2+ plus 100 μ] luniinol (200 μηιοΐ/ΐ) or
lucigcnin (1 mmol/l) were preincubated at 37 °C for 10 minutes.
The stimulation was started by adding 20 μΐ of opsonizcd zymosan
( 1 : 1 0 diluted). The reaction was monitored at 37 °C for 50 min-
utes.
HOC1 assay
The HOC1 production of polymorphonuclear leukocytes (3.75
X 10'Vl) was measured by the chlorination of taurine followed by
the oxidation of 5-thio-2-nilrobenzoic acid to 5,5'-dithio-bis(2-
nitrobenzoic acid) (12). Polymorphonuclear leukocytes (1 ml) were
incubated in Hanks' balanced salt solution/taurine (15 mmol/1) and
stimulated with 100 μΐ opsonized zymosan (stock suspension 1 : 1 0
diluted) at 37 °C for 30 minutes. After slopping the reaction by
adding catalasc (290 unils), samples were centrifuged at 12000g
for 10 minutes. The supernatant was mixed with freshly prepared
and diluted 5-thio-2-nitrobenzoic acid solution (~~ 2 mmol/1) and
immediately measured at 412 nm in a UV-spectrometer (LKJ3
Ultrospec Plus; Pharmacia, Freiburg, Germany). The amount of
HOC1 produced was calculated using the molar linear absorption
coefficient ε = 1410 m2/mol in consideration of the dilution factor
(13). Negative controls were prepared by adding Na-azide (100
μιτιοΐ/ΐ), /.-methionine (1 mmol/1) and catalase (290 units) to the
same cell concentration and opsonized zymosan as stimulator.
Chemiluminescence test condi t ions
Chemiluminescence assays were performed on a Biolumat (LB
9505; Berthold, Wildbad, Germany). The results were evaluated
with an Apple II using the ΈΙΟ' program. Samples of whole hepa-
rinized blood were first diluted 1 : 100 with phosphate buffered
saline. Diluted blood (200 μΐ) samples plus 680 μΐ phosphate buf-
S ta t i s t i c s
The data are expressed as mean (± SD if η ^  3). Statistical com-
parisons were performed with Mann-Wliitney U-tesl (a: 0.05) and
using linear regression.
Results
I d e n t i f i c a t i o n of mye loperox idase def ic ien t
i n d i v i d u a l s using the H3
Figure 1 shows the leukograms (peroxidase activity) of
five probands (proband 1-5) with different myeloper-
oxidase deficiencies compared to those of a normal per-
son (control) and a proband (proband 6) with eosinophil
peroxidase deficiency. Three of the five myeloperoxi-
dase deficient probands showed extremely low mean
peroxidase indices (—53 or less). Therefore, their neu-
trophil clusters were clearly shifted to the left. However,
in only one out of these three persons 1—3 were the
neutrophils and monocytes completely located in the
large unstained cell area (fig. l, proband l), suggesting
Control Proband l Proband 2 Proband 3
Proband 4 Proband 5 Proband 6
Fig. l Leukograms of the Bayer/Technicon H3 of a normal donor
(control), five myeloperoxidase deficient donors of different de-
grees (proband 1-5) and one blood count presenting the rare defi-
ciency of eosinophil peroxidase (proband 6). Light-scattering is
plotted on the y-axis, the myeloperoxidase activity is plotted on
Corresponding microscopic analyses
the x-axis. The numbers indicate the following cells: 1 neutrophils,
2 eosinophils, 3 monocytes. 4 lymphocytes, 5 large unstained cells.
Corresponding microscopic analyses of the blood cells are as fol-
lows:
Mean peroxidase Neutrophils
index . (%)
Control
Proband l
Proband 2
Proband 3
Proband 4
Proband 5
Proband 6
+3.2
-59.1
-59.3
-53.3
-42.8
-32.6
-22.5
55
66
54
67
68
63
31
Eosinophils
(%)
3
4
0
1
1
2
18
Monocytes
(%)
5
5
8
5
6
2
7
Lymphocytes
(%)
37
25
38
27
25
33
44
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Tab. 1 Mean pcroxidase index, myeloperoxidasc mass
[ng/106 granulocytcs], HOCI production [nmol HOC1/30 min] and
phagocytic activity [%] of normal (control, was set as 100%) and
myeloperoxidase deficient cells [proband 1—5]. The HOCI
production was measured using 1 ml isolated granulocytes (3.75
X 109/1) and opsonized zymosan as a stimulus. Phagocytosis was
measured in whole blood after incubation with fluoresccin isothip-
cyanate-labeled E. coli.
Control
Mean peroxidase index —4.6 ± 3.3
Myeloperoxidase mass 1053
(ng/106 granulocytes)
HOCI production 446 ± 52
(nmol/30 min)
Phagocytic activity/ 98.2 ± 0.8
granulocyte population
(% of normal)
Phagocytic activity/ 100
single granulocyte
(% of normal)
Proband no.
1
-54 ± 4.8
0
0
99.1 ±0.3
141 ± 17
2
-57 ±3.1
99
81 ±42
98.7 ± 0.9
155 ±7
3
-53 ± 3.0
156
134 ±31
99.6 ± 0.2
146 ± 15
4
-39 ± 3.0
314
138,· £27
97.9 ± 1.1
122 ± 20
5
-33 ± 2.8
589
158 ± 34
98 ± 1
154 ± 19
Mean ± SD; P1-P5: n = 3; control: n = 6.
that only the cells of this person could be totally myelo-
peroxidase deficient. As will be shown, this could also
be confirmed by other tests. The clusters of eosinophil
granulocytes of persons with myeloperoxidase defi-
ciency did not differ from controls. For comparison, the
leukogram of proband 6 with a very rare form of eosino-
phil peroxidase deficiency is shown in figure 1. Due to
lacking stained vesicles, the light-scattering is changed
characteristically, leading to a cluster location upwards
on the y-axis, and a shift to the left on the x-axis. The
myeloperoxidase activity was normal (as shown by the
location of the neutrophils in the leukogram). However,
because of the unusual plotting of the eosinophil granu-
locytes, the calculation of the mean peroxidase index
-22.5) is wrong.
Phagocytic behaviour of myeloperoxidase
deficient granulocytes
Ninety-seven to 98% of cells of the whole myeloperoxi-
dase deficient neutrophil population were able to phago-
cytose fluorescein isothiocyanate-labelled E. coli, which
was not different from neutrophils with normal myelo-
peroxidase activity. In contrast, the phagocytic activity
of every single cell in the population was remarkably
higher than in normal controls (tab. 1).
Correlation between myeloperoxidase
activity, myeloperoxidase content and HOCI
production
In order to explore in further detail whether the H3 mea-
surements of myeloperoxidase activity correlated to the
amount of myeloperoxidase in the neutrophils, granulo-
cytes were isolated and myeloperoxidase concentration
was assayed using a myeloperoxidase enzyme immuno-
assay. Figure 2 shows a good linear correlation between
these two quantities (r = 0.97). However, among the
Measurements were carried out during a time period of 9 months.
three probands with a very low mean peroxidase index
(below —53), myeloperoxidase was completely absent
only in one person (proband l). In accordance with this
finding, only the neutrophils of this person were unable
to produce HOCI (tab. 1). Although the mean peroxidase
index indicated for proband 2 was comparably low, de-
tectable amounts of myeloperoxidase (enzyme immuno-
assay) and low HOCI production were found in her neu-
trophils (tab. 1). Obviously, the mean peroxidase index
cannot be calculated with exactness in this very low
range. A more successful way of identifying persons
with complete myeloperoxidase deficiency is the evalua-
tion of the graphic presentation (fig. 1), which clearly
shows that only the neutrophils of proband l are located
completely in the large unstained cell area.
1200-,
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Fig. 2 Comparison between the mean peroxidase index (myelo-
peroxidase activity) measured on the Bayer/Technicon H3 and the
myeloperoxidase mass [ng/1 Χ 106 granulocytes] analyzed using
an enzyme immunoassay. r = 0.97, y = 19x + 1165.
α Proband l A Proband 3 O Proband 5
Ο Proband 2 τ Proband 4 D Control.
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Tab. 2 Luminol- and lucigenin-enhanced chemiluminescence of
normal and myeloperoxidase deficient cells during Stimulation of
opsonized zymosan.
Data are presented as integral counts (0-60 minutes), peak and
ti/2fai i (time period when peak dropped to half ot its value) and
expressed as mean of two experiments.
Chem i him i nescence
Luminol
Integral [103 counts/min]
Peak [103 counts/min]
t./7 [min]
Lucigenin
Integral [103 counts/min]
Peak [103 counts/min]
ti/2 [min]
Control
47294
1586
42
31668
888
50
Proband no.
1
5716
126
>60
93542
2390
59
2
29721
834
53
85624
2143
>60
3
49037
1574
41
97948
2420
60
4
51976
1666
49
47563
1106
>60
5
32706
1039
48
44356
1121
>60
Chemiluminescence assay with normal and
myeloperoxidase negative granulocytes
Chemiluminescence tests with luminol and lucigenin
showed characteristic differences between myeloperoxi-
dase negative and myeloperoxidase positive cells. The
cells of proband 1 which were unable to produce HOC1
(see tabs. 1 and 2) showed a drastic decrease of luminol
dependent chemiluminescence compared to controls
(fig. 3a). In contrast, the lucigenin dependent chemilu-
minescence was remarkably enhanced compared to the
control. The higher signals of lucigenin mediated chemi-
luminescence correspond with the higher Superoxide an-
ion production measured by the ferricytochrome c
method after stimulation with phorbol myristate acetate
[20 μ^]. Proband 1 produced 119 nmol/3.75 X 10s
cells per 30 min compared to the 88 nmol/3.75 X 105
cells per 30 min of the control. Furthermore, the duration
of photon emission lasted longer than in normal controls
(indicated as ti/2fall: the time period when the chemilumi-
nescence peak maximum dropped to half of its value;
fig. 3) (tab. 2). A similar pattern in lucigenin chemilumi-
nescence was also detected in partially myeloperoxidase
deficient granulocytes compared with controls.
O2 consumpt ion and H2O2 steadystate
concentration of normal and myeloperoxidase
deficient granulocytes
Oxygen consumption and H2O2 steadystate concentra-
tion were determined after the activation of isolated
granulocytes with opsonized zymosan in a Clark
electrode (3.75 Χ 106 cells/1 ml incubation buffer) (fig.
4). Within the first 5 minutes there was no great differ-
ence of net oxygen consumption between normal and
myeloperoxidase deficient granulocytes [169 ± 20
nmol/3.75 X 106 cells per 5 min (control) vs. 153 ± 10
nmol/3.75 X 106 cells per 5 min (proband 1), mean of 3
independent experiments, ± SD]. It was expected that
the H2O2 concentration of myeloperoxidase deficient
granulocytes (proband l) would be higher due to their
inability to convert it to HOC1. Indeed, there was a
slightly higher H2O2 concentration in myeloperoxidase
negative cells: 6.21 ±4.4 nmol/3.75 Χ 106 cells per
15 IS 24 30 36 42 48 54
t [min]
Proband l
Γ8 2'4 3'0 3'6 4'2 4'8 5'4 6'0
t [min]
Fig. 3 Chemiluminescence measurement of the cells (whole
blood diluted 1 : 100 with phosphate buffered saline) from pro-
band 1 with total myeloperoxidase deficiency compared to a con-
trol.
a: Luminol-enhanced chemiluminescence after stimulation with
opsonized zymosan.
b: Lucigenin-enhanced chemiluminescence after stimulation with
opsonized zymosan.
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Fig. 4 a Oxygen consumption and concentration of H2O2 mea-
sured with the Clark electrode. Granulocytes, 1 ml (3.75 X 109/1)
were incubated in the reaction chamber and stimulated with opson-
ized zymosan. After an incubation period of about 5 minutes the
steadystate concentration of H20-> was determined by adding cata-
lase (60 kU/1).
Fig. 4 b H2O2 calibration curve was established by addition of
different amounts of H202 to the incubation buffer containing cata-
lase according to the equation:
H202 Catalase , H20 + 1/2 02
20 40 60 80 100
H2O2 [μπιοΐ/ΐ]
Arrows: Stepwise addition of Na-dithionite (ΙΟ μΙ of a half-satu-
rated solution) to reduce the oxygen content in the reaction cham-
ber before starting the reaction.
Numbers: addition of Η?Ο·> standards [μηηοΐ/ΐ] 1: 1.0: 2: 1.25; 3-
2.5; 4: 5.0; 5: 10.0; 6: 20,0; 7: 40.0; 8: 50.0; 9: 100.0.'
Fig. 4 c H2O2 calibration curve according to the data of fig. 4b
(r = 0.988, y = 0.51 χ + 1.0).
5 min (proband 1) vs. 4.83 ± 5.0 nmol/3.75 Χ 106 cells
per 5 min (n = 3). However, the steadystate concentra-
tion of H2O2 was rather low, not only in normal granulo-
cytes as expected, but also in myeloperoxidase deficient
granulocytes. H2O2 was determined 5 minutes after ad-
dition of the stimulus zymosan by adding catalase, con-
sidering the fact that H2O2 can easily penetrate cell
membranes and exit the cells (14). As can be arbitrarily
calculated from one experiment shown in figure 4 and
from equation (1), 161 + 80.5 =241.5 nmol oxygen
were consumed by normal granulocytes during the first
5 minutes, which could, theoretically, allow a maximal
production of 80.5 nmol H2O2.
[2 02 + 2 NADPH — 2 HO2
+ 2 Οί -> H202 + 02]
2 H
(Eq. 1)
However, only 3.02 nmol/3.75 X 106 cells per 5 min
H2O2 were detected in normal granulocytes and 5.44
nmol/3.75 Χ 106 cells per 5 min in myeloperoxidase de-
ficient granulocytes. Since myeloperoxidase positive
and negative granulocytes probably do not differ in their
catalase and glutathione-peroxidase activities (15, 16), it
is obvious that myeloperoxidase deficient granulocytes
use other compensatory H2O2 consuming pathways for
generating antimicrobial oxygen species (e. g. OH-radi-
cals), instead of generating HOC1.
Discussion
Correlat ion between myeloperoxidase
activity, myeloperoxidase content and HOC1
product ion
Mean peroxidase indices below -55 are generally
thought to reflect a total myeloperoxidase deficiency
(17). However, in granulocytes with very low myeloper-
oxidase activity, these values may not be estimated with
exactness. In our opinion, much better results are
achieved by considering the graphical presentation, i. e.
whether the neutrophils (and monocytes) are completely
in the large unstained cell area or slightly shifted to the
right (fig. 1). Neutrophils/monocytes of proband l,
which were clearly located in the large unstained cell
region, did not give a signal in the myeloperoxidase
enzyme immunoassay. Generally, there was a good
correlation between myeloperoxidase activity (Bayer/
Technicon H3) and the amount of myeloperoxidase in
cell extracts measured by the enzyme immunoassay
(fig. 2).
However, it should be noted that even in the complete
absence of myeloperoxidase activity, enzyme immuno-
assay signals could be positive since there is a cross-
reactivity between eosinophil peroxidase and myeloper-
oxidase (18). In experiments using cell extracts of neu-
trophils and eosinophils previously separated by the
magnetic activated cell sorter technique, using anti-
CD 16 antibodies, we observed this cross-reactivity: In
extracts of 106 neutrophils (purity: 98%), 370 ng myelo-
peroxidase could be detected, in 106 eosinophils (purity:
82%, 18% neutrophils and monocytes) an amount of eo-
sinophil peroxidase, which corresponded to 115 ng of
myeloperoxidase. Comparing 106 neutrophils with 106
eosinophils (the real amount of eosinophil peroxidase
was not known), the net eosinophil peroxidase/myeio-
peroxidase cross-reactivity (subtraction of the 18%)
would be about 10% and can therefore be neglected un-
der normal conditions (whole blood), where the amount
of neutrophils is significantly higher than the amount of
eosinophils. According to the manufacturer (Biermann,
Bad Nauheim, Germany), the cross-reactivity of eonsi-
nophil peroxidase with myeloperoxidase is lower than
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2%. In extracts of granulocytes of proband l we could
not find any peroxidase using the enzyme immunoassay.
Obviously, the amount of eosinophils was too small to
detect any eosinophil peroxidase crossreactivity. Since
HOC1 production was also lacking, proband l could de-
finitively be regarded as completely myeloperoxidase
deficient. The other proband with a comparably low
mean peroxidase index (proband 2) was only partially
myeloperoxidase deficient, which was demonstrated by
the graphic presentation on Bayer/Technicon H3 (fig. 1),
positive peroxidase values in the enzyme immunoassay
(tab. 1) and production of HOC1 (tab. 1).
Phagocytosis , chemi luminescence and the
respiratory burst
The chemiluminescence measurement of activated gran-
ulocytes with luminol and lucigenin gives an overall pic-
ture of the oxidative metabolism without a strong corre-
lation to a distinct kind of reactive oxygen compound.
However, it is known that luminol chemiluminescence
rather reflects myeloperoxidase/H2O2/chIorite-depen-
dent processes (19, 20) whereas lucigenin chemilumi-
nescence is more predictive for O2 -dependent reactions
(21, 22). The luminol dependent chemiluminescence
signal was indeed drastically reduced in the proband
with complete myeloperoxidase deficiency. It was also
clearly diminished in proband 2 with a similar low mean
peroxidase index, but still retained some myeloperoxi-
dase activity. The other three probands with partial mye-
loperoxidase deficiency did not differ from controls to
a greater extent, even if they clearly produced reduced
amounts of HOC). This indicates the complex interplay
between H2O2/HOC1 in the generation of the luminol
dependent chemiluminescence signal (16, 23).
In contrast, myeloperoxidase deficient granulocytes
showed a much higher lucigenin dependent chemilumi-
nescence than normal controls. This characteristically
high increase of lucigenin dependent chemilumines-
cence compared to the striking decrease of luminol de-
pendent chemiluminescence in granulocytes with mye-
loperoxidase deficiency versus normal controls may be
used as a simple test to detect myeloperoxidase deficient
probands, if an automatic blood counter of the Bayer/
Technicon H3-type (measuring myeloperoxidase activ-
ity) is not available. The enhanced Superoxide anion pro-
duction (lucigenin chemiluminescence) in myeloperoxi-
dase deficient cells was described in the literature (15,
16, 23, 24), and may be caused by two main reasons:
Hasui et al. (25) and Stendahl et al.· (26) reported an
enhanced phagocytosis of myeloperoxidase deficient
granulocytes. This report stands in contrast to earlier ob-
servations of Cramer et al. (27) and Larrocha et al. (28),
who demonstrated a normal phagocytic behaviour of the
myeloperoxidase deficient granulocytes. We could con-
firm the results that myeloperoxidase deficient granulo-
cytes are able to phagocytose more particles than normal
ones (tab. 1). The elevated lucigenin dependent chemilu-
minescence observed in all the five myeloperoxidase de-
ficient patients investigated is probably associated with
this enhanced phagocytosis.
The enhanced phagocytosis could be due to increased
receptor expression (complement 3b-, Fc-receptor) on
the surface of myeloperoxidase deficient granulocytes,
which may contribute to the complex pattern of luminol
and lucigenin chemiluminescence (29, 30). In myeloper-
oxidase deficient cells, additional numbers of these re-
ceptors may be more easily translocated from an intra-
cellular pool to the cell membrane during stimulation
(31). This is in agreement with Stendahl et al. (26), who
showed that the addition of extracellular myeloperoxi-
dase in zymosan-activated adherent myeloperoxidase
deficient granulocytes decreased the complement 3b-
and Fc-mediated phagocytosis.
Furthermore, the longer duration of the lucigenin
chemiluminescence signal in myeloperoxidase deficient
granulocytes compared to normal cells (i.e. the pro-
longated fall of chemiluminescence signals after the
peak-maximum, indicated as t./2fan, tab. 2) may also
reflect the fact that inhibition of NADPH-oxidase is
retarded. This is probably due to the absence or low
levels of HOC1, which contributes to the termination
of the respiratory burst in myeloperoxidase-positive
granulocytes (4).
The enhanced production of reactive oxygen compounds
as a result of these effects (enhanced phagocytosis due
to increased complement 3b, Fc-receptor expression and
reduced inhibition of NADPH-oxidase because of the
lack of HOC1 production) may, at least partly, compen-
sate for myeloperoxidase deficiency.
Role of H2O2 in myeloperoxidase def ic ien t
cells
Lack of myeloperoxidase implies the missing formation
of HOC1 from H2O2, which is a process with a high
turnover rate. It was, therefore, expected that the
steadystate concentration of H2O2 would be signifi-
cantly higher in myeloperoxidase deficient cells after ac-
tivation. However, although a slightly elevated H2O2
concentration could be detected, the absolute concentra-
tion was rather low in both myeloperoxidase positive
and negative cells. Nauseef et al. (15) and Locksley et
al. (16) detected normal endogenous amounts of catalase
and glutathione-peroxidase in myeloperoxidase deficient
granulocytes and monocytes, indicating a normal H2O2
scavenging system in deficient cells. This finding obvi-
ously points to the effective transformation of H2O2 into
other reactive oxygen substrates in the absence of mye-
loperoxidase, which may be compensatorily cytotoxic.
The exact species are presently not known (32). Possible
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candidates in granulocytes and monocytes could be OH- (33). The experiments for the identification of these al-
radicals, NO/ONOO formation, as well as substances ternative H2O2-pathways in myeloperoxidase deficient
such as neopterin, which was previously described as an cells are in progress,
enhancer of cytotoxic effects of H2O2 against E. call
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